"PLEASE NOTE: During the COVID-19 crisis, Whitman-Walker will close all walk-in services. Whitman-Walker will offer other services through video and audio telehealth appointments. Our locations at 1525 14th Street, NW and Max Robinson Center at 2301 Martin Luther King, Jr. Ave, SE will remain open for appointment-only care including COVID-19 testing and URGENT care appointments. HIV/STI testing is available by appointment only at LIZ at 1377 R Street, NW, 2nd floor and Max Robinson Center. Call 202.797.4439 to schedule. Whitman-Walker Youth Services in Eastern Market is closed until further notice. See updates to our services and hours of operation on our website."

During the past decade, Whitman Walker Clinic conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 40 clinical trials were completed, i.e. on average, 111.1% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 12 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Whitman Walker Clinic" #1 sponsor was "Gilead Sciences" with 35 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 13 trials sponsored, "AIDS Clinical Trials Group" with 9 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored and "Glaxo Wellcome" with 3 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Whitman Walker Clinic" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 11 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Glaxo Wellcome" with 2 trials as a collaborator and "San Francisco Department of Public Health" with 2 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Whitman Walker Clinic" are "HIV Infections" (42 trials), "HIV-1 Infection" (17 trials), "HIV" (11 trials), "Acquired Immunodeficiency Syndrome" (5 trials) and "Chronic Hepatitis C" (4 trials). Many other conditions were trialed in "Whitman Walker Clinic" in a lesser frequency.

Most popular intervention types in "Whitman Walker Clinic" are "Drug" (76 trials), "Biological" (4 trials), "Other" (3 trials), "Behavioral" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "E/C/F/TAF" (7 trials), "FTC/TDF" (7 trials), "ATV" (6 trials), "COBI" (6 trials) and "E/C/F/TDF" (6 trials). Other intervention names were less common.

The vast majority of trials in "Whitman Walker Clinic" are 85 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Whitman Walker Clinic". undefined are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 64 completed trials in Whitman Walker Clinic, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Whitman Walker Clinic, 3 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 7 trials that are defined as “Not Applicable".